< Back to previous page

Project

NEURONET - Phase III (R-12638)

NEURONET wants to study from a biomedical point of view, nerve diseases like Alzheimer dementia, Parkinson and the disease of Charcot-Marie-Tooth. The degeneration of the nerve cells with all these diseases is a complex proces where as well genetic as environmental aspects have an effect. The Methusalem-project NEURONET collects biological material of patients and family to look into the mechanisms that are the basis of neurodegeneration. Next to that, NEURONET wants to contribute the development of new medicines.
Date:1 Feb 2022 →  Today
Keywords:NEUROSIS
Disciplines:Autoimmunity, Neurological and neuromuscular diseases